Nuvalent Inc [NUVL] stock is trading at $82.95, down -1.94%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NUVL shares have gain 5.31% over the last week, with a monthly amount glided 6.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Nuvalent Inc [NASDAQ: NUVL] stock has seen the most recent analyst activity on March 14, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $100 for it. Previously, H.C. Wainwright started tracking the stock with Buy rating on December 30, 2024, and set its price target to $110. On October 24, 2024, UBS initiated with a Neutral rating and assigned a price target of $100 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $100 on August 29, 2024. Jefferies initiated its recommendation with a Buy and recommended $97 as its price target on April 17, 2024. Leerink Partners upgraded its rating to Outperform for this stock on April 01, 2024, and upped its price target to $110.
Nuvalent Inc [NUVL] stock has fluctuated between $55.53 and $113.51 over the past year. Currently, Wall Street analysts expect the stock to reach $130 within the next 12 months. Nuvalent Inc [NASDAQ: NUVL] shares were valued at $82.95 at the most recent close of the market. An investor can expect a potential return of 56.72% based on the average NUVL price forecast.
Analyzing the NUVL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.31 and Total Capital is -0.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 80.78 points at the first support level, and at 78.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 85.31, and for the 2nd resistance point, it is at 87.67.
Ratios To Look Out For
For context, Nuvalent Inc’s Current Ratio is 14.48. Also, the Quick Ratio is 14.48, while the Cash Ratio stands at 1.61.
Transactions by insiders
Recent insider trading involved James Richard Porter, Officer, that happened on Jul 15 ’25 when 81000.0 shares were purchased. Chief Scientific Officer, Pelish Henry E. completed a deal on Jul 10 ’25 to sell 5500.0 shares. Meanwhile, Chief Scientific Officer Pelish Henry E. sold 2145.0 shares on Jul 09 ’25.
